Phase I trial of veliparib or mitomycin C + veliparib in pts with Fanconi anemia pathway (FA) repair defects

Category Primary study
JournalMolecular Cancer Therapeutics
Year 2011
This article has no abstract
Epistemonikos ID: 8a818a495e5ca3f84a1742af64769530b28cecff
First added on: Feb 04, 2025